Walgreens Boots Alliance, Inc. (NYSE:WBA) reported its Q4 results, with EPS of $0.80 coming in better than the Street estimate of $0.77. Revenue was $32.4 billion, compared to the Street estimate of $32.07 billion.
For fiscal 2023, the company expects EPS to be in the range of $4.45-$4.65, compared to the Street estimate of $4.53.
RBC Capital analysts view Q4 results as decent, slightly ahead of the Street estimates on solid SS retail and international growth despite difficult comps.
The analysts view near-term share recapture to achieve ex-COVID script growth of 5% as a show-me story for now. The analysts lowered their price target to $36 from $42 while reiterating their sector perform rating.
